APPENDIX I – UNODA

1. Description of the trigger(s) of suspicion of alleged use of CBT weapons (e.g., outbreak of non-endemic disease,

specific event), including the date, time, and subsequent timeline of events related to the alleged use

2. Tentative conclusion regarding alleged attack and, if possible and/or desirable, identification of possible perpetrator

3. Identification of the location

(a) location name

(b) geographic (GPS) co-ordinates

(c) in relation to another known location (by direction and distance)

4. Characteristics of the site(s)

(a) military (type)

(b) civil (city, rural area, town, buildings affected)

(c) nature of the terrain (relief, vegetation)

(d) accessibility of the site

5. Meteorological conditions

6. Methods of dissemination used

(a) weapons:

(i) aerial bombs

(ii) rockets

(iii) artillery

(iv) spray devices

(v) others

(b) animal and arthropod vectors

(c) others (e.g., air, food, water)

7. Extent of the weapons used

(a) surface(s) affected

(b) number and duration of weapons used

8. Characteristics of the possible CBT agent

(a) preliminary identification

(b) type, consistency, and persistency of contamination

(i) contamination of equipment and buildings

(c) formulation

(d) transmissibility

9. Effects on humans

(a) estimated number of fatalities

(b) number of victims

(i) hospitalized

(ii) other

(c) signs and symptoms

(i) at the time of the attack

(ii) delayed onset

(d) epidemiological data

(e) treatments and/or other countermeasures used

(f) response to treatments and/or countermeasures

10. Effects on animals

(a) signs and symptoms

(b) epidemiological data

(c) treatments and/or other countermeasures used

(d) response to treatments and/or countermeasures

11. Effects on vegetation and crops

(a) signs of contamination

(b) signs and symptoms

(c) epidemiological data

(d) treatments and/or other countermeasures used

(e) response to treatments and/or countermeasures

12. Samples

(a) types of samples identified in situ, including any unexploded munitions or remnants of munitions

(b) types of samples analyzed

(c) results of available analyses

(d) types of samples accompanying the report

(e) documentation system for the sampling process

13. Request for medical assistance, and the nature of such assistance

14. Request for technical assistance (detection, decontamination etc.)

15. If the requesting state and the receiving state are the same, for planning purposes, indication of the modalities and assistance available to support an investigation:

(a) logistics

(i) transportation

(ii) housing

(iii) food/water

(iv) utilities

(b) medical support:

(i) for collection of clinical samples

(ii) for the investigation team

(c) sample storage

(i) secure storage location

(ii) refrigeration

(d) interpreters

(e) expertise in dangerous good packaging, transport

(f) point of entry or other suggested safe routes of access for the team to the investigation site(s)

(g) 24-hour point of contact, including telephone, e-mail, and facsimile.

Types of information to be provided as available by a Member State to the Secretary-General in reporting the possible use of chemical, biological, or toxin (CBT) weapons